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Wehaveutilixedthehuman4F2 heavychain(4F2HC)geneasamodelsystem 
in studies designed to elucidate the molecular events involved in regulating 
inducible gene expression during normal human T-cell activation. In pre- 
vious studies we have shown that steady state levels of 4F2HC mRNA are 
induced 50-60-fold within 6 h of T-cell activation by phytohemagluttinin 
(PHA) and that the induction of 4F2HC gene expression involves both the 
protein kinase C and calcium-mediated activation pathways. Despite the 
fact that the 4F2HC gene is highly regulated in T cells, the 5’ upstream 
region of the 4F2HC gene contains a housekeeping promoter which is G + C 
rich, lacks TATA or CCAAT sequences, and contains four potential bind- 
ing sites for the ubiquitous Spl transcription factor. The major regulatory 
elements of the 4F2HC gene do not reside within this 5’ upstream region but 
instead, map to the exon 1-intron 1 region of the gene. The low levels of 
mature 4F2HC mRNA in resting T cells result from a block to transcription 
elongation within the exon 1-intron 1 region of the gene rather than pro- 
moter inactivity. Phorbol ester stimulation of resting T cells induces 
4F2HC gene expression by removing this block to transcription elongation. 
We now report that in addition to its ability to serve as a transcriptional 
attenuator, the 4F2HC first intron contains a powerful enhancer element 
which is active in a wide variety of cell types including malignant human T 
cells. Full enhancer activity is displayed by a 186 bp fragment of the first 
intron which contains binding sites for two novel nuclear proteins (NF-4FA 
and NF-4FB) which flank a consensus binding site for the AP-1 transcrip- 
tion factor. A cDNA encoding the NF-4FB enhancer binding protein has 
been cloned by screening a lambda gtl 1 cDNA library with a rabiolabelled 
oligonucleotide corresponding to the NF-4FB recognition sequence. 
Correspondence should be addressed to Dr J. Leiden, HHMI, MSRBI Rm 4510.1150 West Medical 
Campus Drive, University of Michigan Medical Center, Ann Arbor, MI 48109, USA. 
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Introduction 
Antigen recognition by the heterodimeric a/P receptor of human T lymphocytes 
results in a complex and precisely orchestrated set of changes in T-cell gene expres- 
sion including the induction of a set of nuclear proto-oncogenes [ 1,2], the production 
of a variety of soluble lymphokines [3], and the expression of a novel group of cell- 
surface antigens [4]. While a great deal has recently been learned about the structural 
requirements of antigen recognition by the TCR a/P molecule (reviewed in [5]), 
relatively less is understood about the molecular mechanisms involved in modulating 
coordinate gene expression during T-cell activation. Cross-linking of the TCR a/P- 
CD3 complex has been shown to result in phosphoinositol turnover, protein kinase 
C activation, and transient increases in cytosolic ionized calcium levels (reviewed 
in [6]). How these (and other) second messengers are subsequently able to modulate 
T-cell gene expression remains unclear. 
We have utilized the 4F2 cell-surface antigen as a model system of gene regulation 
during human T-cell activation. 4F2 is a 120 kD disulphide-linked heterodimer 
composed of an 85 kD glycosylated heavy chain (4F2HC) and a 35 kD non-glycosy- 
lated light chain (4F2LC) [7]. 4F2 is of interest in studies of T-cell activation because 
it is a T-cell activation antigen which is expressed at low levels on resting peripheral 
blood T cells, but rapidly induced following activation with either lectins or antigen 
[4]. Increases in 4F2 cell-surface expression first occur 4 h after lectin stimulation, 
and peak at 16-20 h, well before the onset of DNA synthesis or the appearance of the 
interleukin-2 (IL-2) receptor a chain [4]. In addition, 4F2 appears to be intimately 
involved in the process of T-cell activation because monoclonal antibodies directed 
against the 4F2HC are able to block efficiently the proliferation of cultures of 
activated T cell in vitro [8]. 
We have previously reported that the 4F2HC is encoded by an 1862 bp cDNA [9]. 
DNA sequence analysis of the 4F2HC cDNA demonstrated that it encodes a 529 
amino acid type II membrane glycoprotein composed of an 8 1 aa N-terminal intra- 
cytoplasmic domain, a single hydrophobic putative transmembrane region, and a 
425 aa extracellular domain. The 4F2HC is encoded by a single copy human (and 
murine) gene and does not display significant homology with other known proteins 
[9]. In order to investigate the molecular mechanisms which regulate 4F2HC gene 
expression in resting, activated, and malignant T cells we have recently reported the 
isolation and characterization of a 4F2HC genomic clone [lo]. The 4F2HC gene is 
composed of nine exons and spans 8 kb of the long arm of human chromosome 11 
[lo]. Despite our findings that the gene is highly regulated during T-cell activation, 
the 5’ end of the gene contains a housekeeping promoter which is G + C rich, lacks 
TATA or CCAAT sequence motifs and contains binding sites for the ubiquitous 
Spl transcription factor [ 111. There are DNAaseI hypersensitive sites in both the 5’ 
upstream and first intron regions of the gene [lo]. Taken together, these findings 
suggested that 4F2HC gene expression might be regulated by sequences internal to 
the gene. 
Our previous studies of 4F2HC gene transcription in resting and activated T cells 
have demonstrated that the gene can be synergistically induced by phorbol esters 
which activate protein kinase C and the calcium ionophore, ionomycin [ 121. The 
4F2HC promoter was shown to be equally active in resting and phorbol ester acti- 
vated human peripheral blood T cells [ 121. The low steady state levels of mature 
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4FZHC mRNA found in resting T cells was shown to be the result of a block to 
transcription elongation within the exon 1-intron 1 region of the gene. Phorbol ester 
activation removes this block to transcription elongation resulting in increased levels 
of full-length 4F2HC mRNA [ 121. This phorbol ester induced 4F2HC gene induc- 
tion is inhibited by cycloheximide and therefore requires protein synthesis [ 121. In a 
parallel set of studies, ionomycin treatment of resting T cells was shown to increase 
4F2HC promoter activity [ 121. 
In order to map the sequences responsible for transcriptional attenuation in the 
4F2HC gene we have introduced 4F2HC S-upstream, exon 1, and intron 1 sequences 
into a variety of plasmids containing the bacterial chloramphenicol acetyltransferase 
(CAT) reporter gene. Surprisingly, we found that the 4F2HC first intron contains a 
potent enhancer element which is active in a wide variety of human and murine tissue 
culture cell lines. This enhancer element, which acts on a variety of promoters 
including the SV40 promoter/enhancer, the HSV thymidine kinase (TK) promoter, 
and the 4F2HC promoter has been mapped to a 186 bp AluI/RsaI fragment within the 
4F2HC first intron. The mapping studies have suggested that there are multiple 
enhancer motifs within this DNA fragment. DNAase footprinting and gel mobility 
shift studies revealed that this fragment contains binding sites for two different 
Jurkat nuclear proteins (NF-4FA and NF-4FB). These binding sites are distinct 
from previously described enhancer binding sites. In addition this enhancer frag- 
ment contains a consensus binding site for the AE-1 transcription factor. Using a 
modification of the technique of Singh et al. [13] we have cloned a cDNA which 
encodes the NF-4FB enhancer binding protein. 
Results 
The 4F2HCfirst intron contains a potent enhancer element 
In an attempt to map the sequences responsible for the previously reported [12] 
transcriptional attenuator activity of the 4F2HC gene exon 1-intron 1 region a 
variety of genomic fragments were subcloned into the Hind111 site of the pSV2cat 
[ 141 plasmid between the SV4Q promoter/enhancer and the bacterial chlorampheni- 
co1 acetyltransferase (CAT) reporter gene (Figure I). These constructs were trans- 
fected into human Jurkat T cells using DEAE-dextran [lo]. Somewhat surprisingly, 
the pSV2-1,cat plasmid containing a 509 bp 4F2HC genomic fragment which in- 
cludes the entire 4F2HC first intron surrounded by short regions of exon 1 and 
exon 2 sequences in order to allow for accurate splicing (Figure 1; pSV2-1,cat) dis- 
played 60-fold higher CAT activity, compared with the pSV2cat plasmid alone 
(Figure 2). In order to determine whether this effect was due to an enhancer element, 
or, alternatively, to a cryptic promoter within this region of the 4F2HC gene, this 
same fragment was subcloned in both orientations into the BamHI site which lies 
downstream of the bacterial CAT gene in pSV2cat (Figure 1; pSVZI,Bam/cat and 
pSV2RI,Bam/cat). Both constructs containing the 4F2HC first intron expressed & 
45fold more CAT activity than the pSV2cat control plasmid (Figure 2) indicating 
that this fragment contains a potent enhancer element. In order to determine the 
cellular specificity of this enhancer, the identical CAT constructs were used to trans- 
feet a variety of human and murine cell lines including K562 human erthroleukemia 
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Figure 1. A schematic representation of CAT reporter plasmids. The 509 bp StuI/SacI fragment 
containing the human 4F2HC first intron (4F21,) [lo] was cloned into the previously described pSV2cat 
plasmid [14] either at the Hind111 site located between the SV40 promoter/enhancer (SV40 P/E) and the 
bacterial CAT gene (pSV2-1,cat) or at the BamHI site located downstream of the bacterial CAT reporter 
gene in pSV2cat. Downstream constructs containing the 4F2HC first intron in either a 5’ to 3’ (pSV2- 
1,Barn cat) or a 3’ to 5’ (pSV2-RI,Bam cat) were obtained. Similar constructs (p4F2cat and p4F2-1,Bam 
cat) were made by replacing the SV40 promoter/enhancer in the pSV2cat plasmid with a promoter 
fragment (4F2 P) (bp-5&W-+ 101) from the human 4F2HC 5’ upstream region [lo]. 
cells, JY human B cells, murine L cell fibroblasts, and murine EL4 T cells. In all 
cases the 4F2HC first intron was able to increase transcription from the SV40 pro- 
moter/enhancer by 2-%-fold (Figure 2). However, it is worth noting that the 
enhancer was less active in both human B cells and mouse L cells. Part of this 
difference was due to the fact that the SV40 promoter/enhancer displayed higher 
basal levels of CAT activity in these cells. In a parallel series of experiments, the 
4F2HC first intron was also shown to function as a potent enhancer of both the 
4F2HC and Herpes simplex virus (HSV) thymidine kinase (TK) promoters result- 
ing in 5-lo-fold increases in the activity of these promoters in Jurkat cells (data not 
shown). Taken together these experiments indicated that the first intron of the 
4F2HC gene contains a powerful classical enhancer element which can function with 
a number of heterologous promoters in an orientation and position independent 
fashion in a wide variety of cell types. The potency of this enhancer is rather remark- 
able in that it is able to significantly increase transcription in T cells even in the 
presence of the SV40 enhancer element (Figure 2). 
Mapping of the 4F2HC enhancer 
In order to map more precisely the enhancer element, a variety of restriction enzyme 
fragments from the 4F2HC first intron were subcloned into the BamHI site down- 
stream of the bacterial CAT gene in pSV2cat and assayed for their ability to enhance 
CAT transcription in Jurkat cells (Figure 3). Fragments from the left half of the 
intron (bp G250) or the right half of the intron (bp 253-509) produced by digestion 
with NarI or HaeII displayed a marked reduction in enhancer function although 
both fragments retained the ability to enhance CAT expression by 10-15 fold as 
compared to the pSV2cat control plasmid. In contrast the 186 bp AluI/RsaI frag- 
ment from the middle of the intron displayed full enhancer activity (Figure 3). These 
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Figure 2. The effects of the 4F2 heavy chain first intron on SV40 promoter/enhancer activity in a variety 
of human and murine cell lines. The pSV2cat, pSV2-&cat, pSV2-I,Bam/cat, and pSV2-RI,Bam/cat 
plasmids (see Figure 1) were used to transfect human Jurkat T cells, K562 erythroleukemia cells, and JY B 
cells as well as murine L-cell fibroblasts and EL4 T cells using a modification of the DEAE-dextran 
approach as previously described [lo]. Forty-eight hours following transfection, cells were harvested and 
cell extracts normalized for protein content were assayed for CAT activity using standard techniques and 
thin layer chromatography (141. Spots containing acetylated chloramphenicol were cut from the TLC 
plates and quantitated by liquid scintillation counting. The CAT activity produced by a control pSV2 cat 
plasmid was normalized to a value of 1 in each of the experiments. 
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Figure 3. Mapping of the 4F2HC first intron enhancer element. Restriction enzyme fragments derived 
from the human 4F2HC first intron were cloned into the BamHI site downstream of the bacterial CAT 
gene in the pSV2cat plasmid vector. These constructs were used to transfect human Jurkat cells as 
described in the legend to Figure 2. Two days following transfection, the cell extracts were assayed for 
bacterial CAT activity as described in the legend to Figure 2. As an internal control, the CAT activity 
produced by the pSV2cat plasmid was normalized to a value of 1. The upper left panel shows a partial 
restriction endonuclease map of the human 4F2HC first intron. Restriction enzyme fragments used in the 
CAT constructs are shown by rectangular black bars in the lower left panel. The CAT activity produced 
by each of these constructs is shown as normalized acetylation in the bottom right hand graph. The NF- 
4FA, AR-1 and NF-4FB nuclear protein binding sites as described in the legend to Figure 4 are shown in 
the restriction endonuclease map in the upper left panel. 
results demonstrated that while all of the enhancer sequences map to a relatively 
small fragment from the center of the intron, sequences on both sides of the NarI site 
(bp 250) are needed for full enhancer activity. Thus either the NarI site lies in the 
middle of a single enhancer motif or there are multiple enhancer motifs which flank 
this site. 
The 4F2HC enhancer contains two novel nuclear protein binding sites 
In order to identify putative binding sites for 4F2HC enhancer binding proteins, 
restriction enzyme fragments from the 4F2HC first intron were subjected to 
DNAaseI footprint analyses using nuclear extracts prepared from Jurkat T cells 
(Figure 4). Two sites (NF-4FA and NF-4FB) within the AluI/RsaI enhancer frag- 
ment were specifically protected by Jurkat nuclear proteins. Interestingly these two 
sites surround a consensus binding site for the AR-1 transcription factor [ 15, 161 
which is not footprinted by the unstimulated Jurkat nuclear extracts. It is also worth 
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Figure 5. A gel mobility shift analysis of the (A) NF-4FA and (B) NF-4FB nuclear binding proteins. 
Complimentary single-stranded oligonucleotides corresponding to the NF-4FA and NF-4FB nuclear 
protein binding sites as determined in Figure 4 were synthesized using an Applied Biosystems Model 
380B DNA synthesizer. For the sake of convenience, overhanging Bar&II and BglII single-stranded 
compatible ends were included in the appropriate oligonucleotides. Double-stranded oligonucleotides 
were formed by annealing under the appropriate salt and temperature conditions and were labelled using 
the Klenow fragment of DNA polymerase I in the presence of [a-“I’]-dATP. Labelled oligonucleotides 
were purified by electrophoresis in 10% polyacrylamide gels. Binding reactions were as previously 
described [24] and contained 2 pg of Jurkat nuclear protein extract, 10,000 cpm of labelled oligonucleo- 
tide, 0.5 ug of polydI:dC (Pharmacia, Piscataway, NJ, USA) in a total volume of 15 ul. Complexes were 
allowed to form for 15 min at room temperature and were then fractionated on 4% non-denaturing 
polyacrylamide gels as previously described [24]. In cold competitor experiments, complexes were 
allowed to form in the presence of 10-50 ng (2&100-fold molar excess) of unlabelled double-stranded cold 
NF-4FA or NF-4FB competitor. Arrows to the left of each set of gels indicate the positions of bands of 
altered mobility which result from specific interactions of Jurkat nuclear proteins and the NF-4FA and 
NF-4FB double-stranded oligonucleotide probes. 
the enhancer elements present in this fragment (see Figure 3). In order to confirm 
the specificity of the NF-4FA and NF-4FB proteins, synthetic oligonucleotides 
corresponding to the two binding sites were synthesized and used in gel mobility shift 
assays with Jurkat nuclear extracts (Figure 5). Jurkat nuclear extracts contained 
several proteins which were able to bind to the NF-4FA and NF-4FB oligonucleo- 
tides and cause a shift in their electrophoretic mobility. Cold competitor experiments 
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demonstrated that the formation of one of the shifted NF-4FA complexes [shown by 
the arrow in Figure 5(A)] was inhibited by a 5&100-fold molar excess of specific 
unlabelled NF-4FA cold competitor oligonucleotide, but not by an identical amount 
of cold NF-4FB competitor. Similarly, the formation of one of the shifted NF-4FB 
complexes [shown by the arrow in Figure 5(B)] was inhibited by excess cold NF- 
4FB competitor but not by an identical amount of cold NF-4FA competitor. These 
results indicated that the NF-4FA and NF-4FB sequences specifically bind distinct 
Jurkat nuclear proteins. The functional importance of the NF-4FA, NF-4FB, and 
AP-1 sites was underscored by the finding that all three sites are highly conserved in 
the murine 4F2HC first intron which has similar enhancer activity (data not shown), 
while the remainder of the murine and human introns display a significantly lower 
level of homology (data not shown). 
Molecular cloning of a cDNA encoding the NF-4FB enhancer binding protein 
In order to understand better the function of the 4F2HC first intron enhancer, we 
have attempted to clone a cDNA encoding the NF-4FB nuclear binding protein. A 
random hexanucleotide-primed lambda gt 11 cDNA library from the K562 human 
erythroleukemia cell line was screened with a multimeric 32P-labelled oligonucleo- 
tide probe corresponding to the NF4FB binding site using a modification of the, 
technique described by Singh et al. [ 131 and Staudt et al. [ 171 (Figure 6). Multimeric 
probe was constructed by labelling single-stranded oligonucleotides with [Y-~~P]- 
ATP using T4 polynucleotide kinase, annealing the labelled single-stranded oligo- 
nucleotides, and then ligating the annealed oligonucleotides prior to use in the 
screening protocol. This technique was found to produce probes of significantly 
higher specific activity than the labelling technique originally described by Singh 
et al. using the Klenow fragment of DNA polymerase I [13]. Four of the 750,000 
recombinant clones screened produced fusion proteins which bound to the NF-4FB 
oligonucleotide. Of these, three displayed specific binding as they were unable to 
bind similarly prepared oligonucleotide probes corresponding to the NF-4FA bind- 
ing site (Figure 7). One of the clones encoded a non-specific DNA binding protein 
which bound equally to the NF-4FA and NF-4FB probes. 
Discussion 
We have utilized the 4F2HC gene as a model system of coordinate gene regulation 
following T-cell activation. Studies of the structure of the gene as well as its patterns 
of transcription have demonstrated that the gene contains a constitutively active 
housekeeping promoter which includes a calcium responsive element as well as four 
binding sites for the ubiquitous Spl transcription factor [lo, 121. The major regu- 
latory domains of the gene appear to map to the exon 1 -intron 1 region. 4F2HC gene 
expression in resting T cells is down-regulated by a block to transcription elongation 
located between exon 1 and exon 2. Induction of 4F2HC gene expression by phorbol 
esters results from the removal of this block to transcription elongation [ 121. 
The first intron of the 4F2HC gene also contains a powerful enhancer element 
which is active upon a number of heterologous promoters in a wide variety of cell 
types. Full enhancer activity is displayed by a 186 bp fragment which contains 
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Figure 6. A schematic illustration of the cloning of a cDNA encoding the NF-4FB nuclear binding 
protein. Complimentary single-stranded oligonucleotides corresponding to the NF-4PB protein binding 
site were labelled in vitro with [y-3*P]-ATP using T4 polynucleotide kinase. The complimentary oligo- 
nucleotides were annealed in solution and then ligated using their BamHI and BglII compatible ends for 
2 h at room temperature with 10 units of T4 DNA ligase. The ligated multimer probe was purified by 
passage over an elutip-d column (Schleicher and Schuell, Keene, NH). A random hexanucleotide primed 
hgtl 1 cDNA library prepared from the K562 human erythroleukemia cell line was the generous gift of Dr 
Francis Collins. Fifteen 82 x 100 mm filters each containing 50,000 recombinant clones were screened in a 
total volume of 45 ml with the NF-4FB labelled oligonucleotide probe using the method of Staudt et al. 
[ 171. Positive clones were purified to homogeneity by repeated screening and then rescreened using either 
the non-specific (NF-4FA) or the specific (NF-4FB) labelled oligomeric probes. 
tains two nuclear protein binding sites flanking a consensus Al?-1 binding site. The 
importance of each of these sites in determining enhancer activity remains unclear. 
However, it is likely that at least two of the binding sites, (NF-4FB and AP-1 and/or 
NF-4FA) are required for full enhancer activity because cleavage of the enhancer 
fragment with NarI which separates the NF-4FB binding site from the AP-1 and 
NF-4FA sites results in a significant decrease in enhancer activity. The importance 
of the AP-1 site in determining enhancer activity is uncertain given our inability to 
footprint this site with nuclear extracts from Jurkat cells which display prominent 
enhancer activity. On the other hand, it is possible that low levels of AP-1 activity 
(which are not detectable in crude Jurkat nuclear extracts) are sufficient to activate 
the enhancer via this site. It is interesting to note that the AP-l/c-jun transcriptional 
activator has recently been shown to be induced at the mRNA level during serum- 
mediated activation of NIH3T3 cells [18], raising the possibility that AP-l/c-jun 
induction during T-cell activation may be important in activating the 4F2HC 
enhancer element in normal human T cells. Preliminary experiments have indicated 
that the NF-4FA protein is not expressed in K562 cells which display high levels of 
enhancer activity (see Figure 3) raising the possibility that this factor does not play an 
essential role in enhancer function. A final determination of the importance of each of 
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Figure 7. A schematic illustration of the regulatory elements of the human 4F2HC gene. DNAase I 
hypersensitive sites within the 4F2HC gene in resting and activated peripheral blood T cells are shown in 
the top line of the Figure (lo]. EcoRI (R), FokI (F), Stu (St), Sea (SC), PstI (P), and Sac1 (Sa) restriction 
endonuclease sites as well as their relative map positions are shown in the second line of the figure [lo]. The 
exon/intron structure of the gene as well as potential binding sites for the Spl, API, NF-4FA, and NF- 
4FB nuclear binding proteins are shown in the third line of the figure. The horizontal arrow indicates the 
transcription initiation site [lo]. The location of the previously reported calcium responsive element and 
PMA responsive element (transcriptional attenuator) [ 121 as well as the newly described enhancer element 
are shown as horizontal bars on the bottom of the Figure. 
these sequence motifs awaits ongoing experiments designed to test the effects of 
deletion and mutation of each of the individual binding sites on enhancer function. 
Finally, it should be noted that the 4F2HC enhancer is able to increase significantly 
levels of gene expression from both the SV40 promoter/enhancer and the HSVTK 
promoter, making it a useful adjunct in a variety of eukaryotic expression vectors (B. 
Oakley and J. Leiden, unpublished results). 
The relationship between the enhancer element and the previously described 
transcriptional attenuator in the 4F2HC first intron remains unclear. Preliminary 
experiments indicate that the sequences responsible for transcriptional attenuation 
of 4F2HC gene transcription may map to the 5’ end of the first exon (data not shown). 
It is possible that inactivity of the 4F2HC enhancer in resting T cells results in an 
increased probability of premature transcription termination possibly due to an 
exon 1 sequence element which is difficult for the RNA polymerase complex to 
traverse. T-cell activation (via the protein kinase C pathway) might result in 
enhancer activation which, in turn, might stabilize the RNA polymerase complex 
resulting in transcriptional readthrough and increased levels of mature 4F2HC 
mRNA. In testing this model, it will be of interest to determine whether there 
are differences in the DNA binding activities or mRNA levels of the NF-4FB and 
AP-l/c-jun gene products in activated versus resting T cells. Because the process of 
T-cell activation has been shown to result in increases in c-fos mRNA levels, and 
because the c-fos gene product has recently been shown to associate with, and activate 
the AP-1 transcription factor [ 19,201, it is also possible that de novo c-fos transcrip- 
tion and translation is necessary for 4F2HC enhancer activation. This hypothesis is 
in accord with our previous finding of a requirement for protein synthesis in 4F2HC 
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gene activation in T cells [12]. Finally the c-myc and c-myb proto-oncogenes have 
recently been reported to be regulated by transcriptional attenuators in their exon l- 
intron 1 regions [21, 221. Given the results of this study, it will be of interest to 
determine whether these genes also contain intragenic enhancer elements. 
The identity of the NF-4FB gene awaits DNA sequence analysis of the isolated 
cDNA clone. It will be of interest to determine whether this protein is related to other 
previously described enhancer binding proteins, in particular whether it contains 
zinc-finger or homeobox DNA binding domains. Because the NF-4FB binding site 
does not resemble previously described enhancer elements, this gene may define a 
novel family of transcriptional activators which are involved in up-regulating the 
expression of other genes which, like the 4F2HC, are involved in cell activation. It 
will also be of interest to determine whether NF-4FB mRNA levels can be correlated 
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